Neurotrophic keratitis is a relatively rare disease that can be difficult to manage, and treatment varies depending on disease stage. In recent years, the development of Oxervate (cenegermin-bkbj ...

Adjunctive corticosteroids not superior to placebo, while adjunctive corneal cross-linking associated with increased scar size.

According to several sources, infectious keratitis is the fifth leading cause of blindness in the world.In the United States, it is further down the list, with just more than 70,000 new cases of ...

The Food and Drug Administration (FDA) has approved the supplemental New Drug Application for Ameluz ® (aminolevulinic acid HCI) topical gel, 10% allowing for a larger field of treatment in ...

Immunotherapy. 2012;4(9):939-945. The percentage of patients achieving complete clearance of their AKs in the 5-FU group was 19, 28.2 and 52.6% in the 1-, 2- and 4-week treatment groups ...

The company’s targeted topical therapeutics pipeline includes SM-020 for the treatment of seborrheic keratosis, SM-030 for the treatment of hyperpigmentation disorders of the skin, and DBI-001 ...